Featured Content

Agency Approves Drug for Adult ADHD 8/19/2008

The FDA has broadened the indications for methylphenidate (Concerta) extended-release tablets in doses of 18 mg to 72 mg/day to include adults with attention-deficit hyperactivity disorder (ADHD).

ADHD

FDA Fast Facts 3/21/2007

Xolair to Get Black Box Warning The FDA requested that Genentech, Inc.

Advertisement